NCT05062239
Post-Operative Atrial Fibrillation After Surgical Aortic Valve Replacement and the Influence of Statins
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 5 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 9 words Show 6 more changesShow less
- Trial completed
- Primary completion date changed from estimate of Feb 1, 2027 to Oct 1, 2026
- Secondary endpoints: details revised at 6 of 22 entries
- Study description expanded, about 17 words
- Site details revised
- Publications: details revised at 47 of 47 entries
- Notable Primary endpoints revised (3)
- Secondary endpoints: 24 to 22
- Minor Study description shortened, about 27 wordsv3
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 1
- Start date changed from estimate of Feb 1, 2022 to Apr 1, 2022
- Study description expanded, about 126 words
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Number of Participants with POAF - In-hospital
Timeframe: In-hospital up to 10 days.
Number of Participants with POAF - Early
Timeframe: Early (≤30 days) incidence of POAF
Duration of POAF in-hospital
Timeframe: In-hospital
Secondary (22)
Number of Participants with NOAF
Rate of all-cause mortality - In-hospital
Rate of all-cause mortality - Early
Rate of all-cause mortality - intermediate
Myocardial injury - Tn
Show 17 moreShow less
Myocardial injury - CKMB
Stroke - Early
Stroke - Intermediate
Trans ischemic attack - Early
Trans ischemic attack - Intermediate
Myocardial infarction - Early
Myocardial infarction - Intermediate
Permanent pacemaker - Early
Permanent pacemaker - Intermediate
ICD implantation - Early
ICD implantation - Intermediate
Acute kidney injury - Early
LVEF
Strain
TAPSE
Length of stay on ICU
Length of stay in hospital
Arms and interventions
ContinuanceActive comparator
Continuance prior statin therapy.
DiscontinuanceExperimental
Discontinuance prior statin therapy. Duration: From 7 to 14 days prior to surgery until 30 days postoperative
Drugs: Discontinuance of treatment with statins 7 to 14 days prior to surgery until 30 days postoperative, No-intervention.
Sites
1 site in 1 country
- Odense University HospitalOdense, Denmark